Pharaoh Neuro

Minneapolis, United States

Pharaoh Neuro develops a neurapheresis cerebrospinal fluid management system for neurological patients.

$20.0M raised

Feb 2026

Series A

Manufacturing Medical Medical Device

Top Investors

Hatteras Venture PartnersArboretum VenturesIAG Capital PartnersLaerdal Million Lives Fund

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Pharaoh Neuro

How much funding has Pharaoh Neuro raised?

Pharaoh Neuro has raised $20.0M in total funding. The most recent round was Series A. The last funding was announced in February 2026.

Who are Pharaoh Neuro's investors?

Pharaoh Neuro's investors include Hatteras Venture Partners, Arboretum Ventures, IAG Capital Partners, Laerdal Million Lives Fund.

Where is Pharaoh Neuro headquartered?

Pharaoh Neuro is headquartered in Minneapolis, United States.

What does Pharaoh Neuro do?

Pharaoh Neuro develops a neurapheresis cerebrospinal fluid management system for neurological patients.

What stage is Pharaoh Neuro at?

Pharaoh Neuro is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 18, 2026.

MLA

"Pharaoh Neuro — Funding & Investors." VCBacked, February 18, 2026, https://www.vcbacked.co/company/pharaoh-neuro. Accessed July 1, 2026.

APA

VCBacked. (2026). Pharaoh Neuro — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/pharaoh-neuro

Wikipedia (cite web)

{{cite web |title=Pharaoh Neuro — Funding & Investors |url=https://www.vcbacked.co/company/pharaoh-neuro |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 18, 2026.

Similar Companies in Manufacturing

View all

Bioplastics4health

Bilbao$819K

Sapphire Technologies